More
Topics
Acne
Cosmetic
Eczema
Infections
Pediatric
Practice Management
Psoriasis
Residents
Rosacea
Skin Cancer
Skin of Color
Advertisement
New research offers additional evidence that mitotic rate may have a role in clinical decision-making.
Jonathan Wolfe, MD
Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.
The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.
A simple patch-style test may help support the need to biopsy suspicious lesions.
A look at another commonly used drug and its potential association with skin cancer risks.
A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?
A recent FDA action calls attention to unfounded claims, but it may create some confusion.
Paul Winnington, Editorial Director
Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.
New recommendations from the United States Preventive Services Task Force seem to limit the PCP's role in patient UV education.
The latest guidelines of care for SCC and BCC endorse the standard of care and show we need additional, high-quality research into non-surgical options.
Lesion-directed exams may save time, but is the limited temporal savings worth it?
Jonathan Wolfe, MD, FAAD
Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.
Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.
More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.
What do dermatologists really think about the benefits of sunscreen?
The burden of disease is growing, despite best efforts to combat melanoma.
Jonathan Wolfe, MD, Section Editor
Can clinical features help determine an individual's melanoma risk?
New research sheds light on pathways through which melanoma may become more aggressive.
A new analysis shows that the association between nevi and melanoma is complex.
New findings offer insight into the possible effects of the popular prescription on melanoma growth.
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
